Skip to main content

Case details

Case Number: App_465385/2023

  • Patent number:
    EP2691529 - AAV2 particle comprising an AAV2 capsid protein and a vector comprising a nucleic acid encoding a tripeptidyl peptidase 1 (TPP1) for use in treating late infantile ceroid lipofuscinosis (LINCL) in a non-rodent mammal by intraventricular injection or ICV delivery.

  • Proceeding type: Application

  • Action/Application: Opt-out

  • Applicants:
    PATERIS Patentanwälte PartmbB Represented by Claudia Schmidt

  • Court Division: appealInstance - seat - Luxembourg

  • Date of Formal receipt: 2023-06-01 17:52:50